Caroline M. Loewy

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Seattle, WA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Michael Byrnes, Attorney-in-Fact for Caroline M. Loewy
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Caroline M. Loewy

Form 4 holding Former Director

Aptose Biosciences Inc.

Security class
Director Stock Option (Right to Buy)
Shares / value
50,000
Estimated value
Report date
18 Jan 2022
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Director

eFFECTOR Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
800
Estimated value
Report date
13 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CymaBay Therapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
22 Mar 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

PhaseBio Pharmaceuticals Inc

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
19 May 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ZOGENIX, INC.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
07 Mar 2022
Price
$26.09
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Caroline M. Loewy

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .